The NYT had an article reporting that a number of states are restricting enrollment in a program that provides drugs for people with AIDS. It notes that the program cost governments an average of $12,000 a year. It would have been mentioning that in the absence of patent protection these drugs would sell for a few hundred dollars per year.
Patent protection for drugs is an extremely costly form of protectionism causing many drugs to be sold at several thousand percent above their free market price. There are almost certainly more efficient mechanisms for supporting prescription drug research. While the Washington Post recently devoted a lead front page article to tariffs on ironing boards, no major news outlet has been interested in discussing the much greater distortions resulting from protection for prescription drugs.